Gut diseases such as inflammatory bowel disease (IBD) are increasingly prevalent worldwide, especially in industrialised countries. In 2015 alone, 250,000 people in the UK were diagnosed with IBD, and 3 million in the United States (1, 2). Symptoms can include pain and swelling of the stomach, bloody diarrhoea, weight loss and extreme tiredness.
A new study in Experimental Physiology proposes a novel, non-invasive test for assessing gut function that may help screen and monitor treatment of gut diseases using only a small sample (1 mL) of blood and stool. How well your gut functions is determined by the gut-blood barrier , a complex multi-layer system. This can be compared to a fine-tuned filter that precisely controls the passage of nutrients and prevents bacteria passing from inside the bowel into the bloodstream.
In those with IBD, and other intestinal diseases, the gut-blood barrier is impaired. Here the intestinal wall is more like a ripped sieve, allowing more bacterial products to pass from the gut into the blood. This is commonly referred to as a leaky gut.
This test measures the concentration of gut bacterial products (produced by bacteria during metabolism) in the patient’s blood and stool. The authors believe that with further research this assessment of gut leakage will be very important in the diagnosis and treatment of IBD and other intestinal diseases.
The usual strategy for diagnosing and monitoring IBD is based on a colonoscopy, which is invasive, often requires anaesthesia, and assesses structural lesions, rather than gut malfunction. Gut disorders can happen before there are visible structural changes, so diagnosing based on functional tests evaluating gut leakage could allow clinicians to detect the disease earlier. While there is no cure for IBD, it is controllable. Early diagnosis would enable patients to control symptoms before they became severe, improving their quality of life.
This new research provides a non-invasive, simple test that could not only be useful for diagnosing IBD, but also other gut disorders, such as celiac disease and food allergies. It’s also helpful for detecting diseases that result in a leaky gut, such as heart failure, high blood pressure and liver ailments.
Marcin Ufnal, senior author on the study said:
“This may be a very important tool for diagnosis and treatment of gut and other diseases, using the leaky gut as a marker for disease, as well as a potential target for treatment. “
Learn more: New, non-invasive test for bowel diseases
The Latest on: Gut diseases
via Google News
The Latest on: Gut diseases
- Single-cell TCR sequencing of gut intraepithelial γδ T cells reveals a vast and diverse repertoire in celiac diseaseon November 14, 2019 at 8:59 am
All prices are NET prices. VAT will be added later in the checkout.
- Viome: Viome announces scientific collaboration with GSK to research the prevention of specific chronic diseaseson November 14, 2019 at 6:10 am
Millions of people suffer from chronic diseases and scientific studies suggest that certain microbes living in the gut can produce protein molecules that mimic parts of human proteins, which can then ...
- Glaxo Wants to Look Inside Your Gut to Discover New Vaccineson November 14, 2019 at 1:35 am
Billionaire philanthropist Bill Gates wrote in an editorial last month that new insights into gut bacteria could help prevent malnutrition, obesity, asthma, allergies as well as some auto-immune ...
- Toxic gut bacteria make alcohol-triggered liver disease more deadlyon November 13, 2019 at 10:57 am
Tens of thousands die from alcoholic liver disease each year in the United States—and some go downhill much faster than others. Now, scientists have found a reason for this disparity: a toxin produced ...
- Bacteriophage targeting of gut bacterium attenuates alcoholic liver diseaseon November 13, 2019 at 10:05 am
Fig. 1: E. faecalis cytolysin is associated with mortality in patients with alcoholic hepatitis. Fig. 2: Transplantation of faeces from cytolysin-positive patients with alcoholic hepatitis exacerbates ...
- Targeting alpha-synuclein in the gut may slow down Parkinson's diseaseon November 13, 2019 at 9:42 am
Aggregates of the protein alpha-synuclein arising in the gut may play a key role in the development of Parkinson's disease (PD). Investigators are testing the hypothesis that by targeting the enteric ...
- Take Control of Your Gut Health With the Most Advanced Microbiome Test Money Can Buyon November 12, 2019 at 1:14 pm
Some studies have even linked gut health to a number of specific diseases and conditions, such as diabetes, obesity, irritable bowel syndrome, and colon cancer. However, because everyone’s gut ...
- Bats don't rely on gut bacteria the way humans doon November 12, 2019 at 11:16 am
Right now, there are trillions of bacteria living in your gut, making up about one percent of your body weight. They're supposed to be there—we need them to help us digest food and fight off diseases.
- What do we know about the gut microbiota in Parkinson's disease?on November 11, 2019 at 7:41 am
Since the discovery that the gut microbiome may play a role in the development of Parkinson's disease (PD), this fresh scientific approach has produced varying results. In this review published in the ...
- Gut Might Influence Whether or Not You Get Alzheimer's Diseaseon November 8, 2019 at 10:13 am
The exact causes and pathophysiological nature of the disease are currently under intense investigation. One of the most recognized pathological events in the cause and progress in AD is the ...
via Bing News